Marina I. Buyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marina I. Buyan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Egor Y. Plotnikov
M. V. Lomonosov Moscow State University
3 shared publications - Nadezda V. Andrianova
Belozersky Institute of Physico‐Chemical Biology Lomonosov Moscow State University Moscow Russia
3 shared publications - A. N. Kuzovlev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia
1 shared publication - Andrey I. Buyan
Institute of Protein Research, Russian Academy of Sciences, Pushchino, Russia
1 shared publication - Anna A. Brezgunova
A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia
1 shared publication - Denis N. Silachev
A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by FSBI SRIGR RAMS in General Reanimatology
- Vol. 22 (5) , 59-75
Comprehensive Assessment of Argon Neuroprotective Effects in Photochemically Induced Stroke
Ischemic stroke remains one of the leading causes of mortality and long-term disability worldwide, and existing treatments are bounded by narrow therapeutic windows and low efficacy. Inert gases, particularly argon, have recently emerged as promising neuroprotectors capable of modulating the cellular response to ischemia. However, the analysis of their effects at the systemic, tissue, and cellular levels remains incomplete. The aim of the study was to provide an comprehensive assessment of the neuroprotective properties of argon in vitro and in vivo using the focal cerebral ischemia model in rats . Materials and methods. A two-stage experimental study was conducted, combining in vivo and in vitro approaches. In vivo, focal ischemic stroke was induced in rats using a model of photochemically initiated thrombosis. The animals with induced stroke were divided into two groups based on inhalation mixture composed of N₂ 70% / O₂ 30% (comparison group I + iN₂, n = 10) and Ar 70% / O₂ 30% (main group I + iAr, n = 10). Additionally, 3 groups were included in the experiment: sham-operated animals (SO, n = 6), subjected to sham surgery without stroke induction, and 2 groups of intact animals receiving three inhalations of studied gas mixtures: Int. + iN₂ , n = 7; Int. + iAr, n = 5. Neurological outcomes were studied in a longitudinal mode, followed by a quantitative assessment of the infarction volume based on MRI data, histological and immunohistochemical analyses (GFAP, Iba-1, S100b, caspase-3, von Willebrand factor, etc.), and quantification of marker proteins involved in the regulation of signaling pathways (Akt/GSK-3, Nrf2, NFκB, IL-1α, IL-6, caspase-3) using western blotting. In vitro cultures of neuronal (SH-SY5Y), glial (C6), and endothelial (Ea.Hy926) cells were incubated in an argon-oxygen medium for 24 hours. Functional studies of cultures included assessment of mitochondrial transmembrane potential and lysosomal activity using confocal microscopy. Results. In an in vivo experiment, argon significantly reduced the volume of damage according to MRI data (I + iN2 21.5 ± 5.9 mm³ vs I + iAr 12.5 ± 4.3 mm³, p = 0.0078), improved neurological recovery (I + N₂ and I + iAr group: on the 3[rd] (7.5 (4.2; 10.2) vs 10.0 (10.0; 12.0), p = 0.0015), 7[th] (8.0 (6.7; 9.2) vs 10.0 (9.0; 12.2), p = 0.038) and 14[th] days of the study (4.5 (2.7; 7.2) vs 12.0 (10.7; 12.2), p = 0.0008), It preserved significant neuronal density in the penumbra ( p = 0.001), and downregulated astroglia and microglia activation. In addition to a significant decrease in caspase-3 expression ( p = 0.002) and modulation of pro-inflammatory cytokines (Ila was significantly lower in the I + iAr group, p = 0.002), there was an apparent activation of cytoprotective signaling pathways (Akt ( p = 0.006) and Nrf2 ( p = 0.019)). In vitro , argon exposure increased the proportion of high-potential mitochondria in neuronal ( p = 0.01) and glial cells ( p < 0.0001), and significantly stimulated lysosomal activity in endothelial cells ( p = 0.0006). Conclusion. This comprehensive study demonstrates that argon has a pronounced neuroprotective effect in a model of ischemic brain damage, manifesting by reduction of ischemic lesion volume, improvement in neurological status, and modulation of key molecular and cellular mechanisms of damage. The results demonstrate that argon activates protective mechanisms both in vivo and vitro. Therefore, argon can be considered as a promising and safe candidate for further preclinical and clinical studies in the field of neuroprotective therapy.
- 13 November 2026
- Published by FSBI SRIGR RAMS in General Reanimatology
- Vol. 22 (5) , 59-75
Open AccessComprehensive Assessment of Argon Neuroprotective Effects in Photochemically Induced Stroke
Ischemic stroke remains one of the leading causes of mortality and long-term disability worldwide, and existing treatments are bounded by narrow therapeutic windows and low efficacy. Inert gases, particularly argon, have recently emerged as promising neuroprotectors capable of modulating the cellular response to ischemia. However, the analysis of their effects at the systemic, tissue, and cellular levels remains incomplete. The aim of the study was to provide an comprehensive assessment of the neuroprotective properties of argon in vitro and in vivo using the focal cerebral ischemia model in rats . Materials and methods. A two-stage experimental study was conducted, combining in vivo and in vitro approaches. In vivo, focal ischemic stroke was induced in rats using a model of photochemically initiated thrombosis. The animals with induced stroke were divided into two groups based on inhalation mixture composed of N₂ 70% / O₂ 30% (comparison group I + iN₂, n = 10) and Ar 70% / O₂ 30% (main group I + iAr, n = 10). Additionally, 3 groups were included in the experiment: sham-operated animals (SO, n = 6), subjected to sham surgery without stroke induction, and 2 groups of intact animals receiving three inhalations of studied gas mixtures: Int. + iN₂ , n = 7; Int. + iAr, n = 5. Neurological outcomes were studied in a longitudinal mode, followed by a quantitative assessment of the infarction volume based on MRI data, histological and immunohistochemical analyses (GFAP, Iba-1, S100b, caspase-3, von Willebrand factor, etc.), and quantification of marker proteins involved in the regulation of signaling pathways (Akt/GSK-3, Nrf2, NFκB, IL-1α, IL-6, caspase-3) using western blotting. In vitro cultures of neuronal (SH-SY5Y), glial (C6), and endothelial (Ea.Hy926) cells were incubated in an argon-oxygen medium for 24 hours. Functional studies of cultures included assessment of mitochondrial transmembrane potential and lysosomal activity using confocal microscopy. Results. In an in vivo experiment, argon significantly reduced the volume of damage according to MRI data (I + iN2 21.5 ± 5.9 mm³ vs I + iAr 12.5 ± 4.3 mm³, p = 0.0078), improved neurological recovery (I + N₂ and I + iAr group: on the 3[rd] (7.5 (4.2; 10.2) vs 10.0 (10.0; 12.0), p = 0.0015), 7[th] (8.0 (6.7; 9.2) vs 10.0 (9.0; 12.2), p = 0.038) and 14[th] days of the study (4.5 (2.7; 7.2) vs 12.0 (10.7; 12.2), p = 0.0008), It preserved significant neuronal density in the penumbra ( p = 0.001), and downregulated astroglia and microglia activation. In addition to a significant decrease in caspase-3 expression ( p = 0.002) and modulation of pro-inflammatory cytokines (Ila was significantly lower in the I + iAr group, p = 0.002), there was an apparent activation of cytoprotective signaling pathways (Akt ( p = 0.006) and Nrf2 ( p = 0.019)). In vitro , argon exposure increased the proportion of high-potential mitochondria in neuronal ( p = 0.01) and glial cells ( p < 0.0001), and significantly stimulated lysosomal activity in endothelial cells ( p = 0.0006). Conclusion. This comprehensive study demonstrates that argon has a pronounced neuroprotective effect in a model of ischemic brain damage, manifesting by reduction of ischemic lesion volume, improvement in neurological status, and modulation of key molecular and cellular mechanisms of damage. The results demonstrate that argon activates protective mechanisms both in vivo and vitro. Therefore, argon can be considered as a promising and safe candidate for further preclinical and clinical studies in the field of neuroprotective therapy.
- Open Access
- 1 January 2026
- Published by Tech Science Press in BIOCELL
- Vol. 50 (7) , 1-10
Organ-Specific Metabolic Adaptations to Acute Injury and Their Modulation by Fumarate
Objectives: Metabolic substrate deficiency is a key factor in many pathologies, with organ vulnerability depending on specialized metabolic profiles. In this study, we aimed to investigate the impact of deprivation stress on mitochondria and cell functions in different cell types and to assess the potential of fumarate, a tricarboxylic acid (TCA) cycle intermediate, to modulate these stress responses. Methods: We assessed the effects of fumarate on cell proliferation and mitochondrial membrane potential under both normal conditions and serum deprivation in vitro in astrocytes, renal epithelial cells, and hepatic stellate cells. Subsequently, we performed bioinformatic analysis of transcriptomic data for brain, kidney, and liver tissues subjected to ischemia to reveal specific patterns of alterations in energy metabolism. Results: Analysis of mitochondria-associated gene expression revealed striking organ-specific differences in transcriptional responses to ischemia, with a significant decrease in expression of genes related to the TCA cycle and electron transport chain in the kidneys and liver, in contrast to the brain. In an in vitro serum deprivation model, fumarate preserved mitochondrial potential in a cell type-specific manner, with optimal concentrations of 12.5 mM for astrocytes (p < 0.05), and 25 mM for renal (p < 0.01) or hepatic cells (p < 0.01). Under normal conditions, fumarate increased mitochondrial potential in astrocytes (p < 0.0001), with weak or no effect on renal and hepatic cells. Estimation of cell number indicates the effects of fumarate on the proliferation of kidney (p < 0.05) and liver (p < 0.0001) cells in normal conditions and cell death after serum deprivation. Conclusion: Bioinformatic analysis demonstrates that ischemic stress induces fundamentally different transcriptional programs in the brain, kidney, and liver, particularly affecting genes involved in mitochondrial bioenergetics. Complementing these findings, our in vitro data identify fumarate as a metabolically active but organ-dependent candidate for tissue protective strategies in substrate deprivation pathologies, like ischemia.
- 1 January 2026
- Published by Tech Science Press in BIOCELL
- Vol. 50 (7) , 1-10
Open AccessOrgan-Specific Metabolic Adaptations to Acute Injury and Their Modulation by Fumarate
Objectives: Metabolic substrate deficiency is a key factor in many pathologies, with organ vulnerability depending on specialized metabolic profiles. In this study, we aimed to investigate the impact of deprivation stress on mitochondria and cell functions in different cell types and to assess the potential of fumarate, a tricarboxylic acid (TCA) cycle intermediate, to modulate these stress responses. Methods: We assessed the effects of fumarate on cell proliferation and mitochondrial membrane potential under both normal conditions and serum deprivation in vitro in astrocytes, renal epithelial cells, and hepatic stellate cells. Subsequently, we performed bioinformatic analysis of transcriptomic data for brain, kidney, and liver tissues subjected to ischemia to reveal specific patterns of alterations in energy metabolism. Results: Analysis of mitochondria-associated gene expression revealed striking organ-specific differences in transcriptional responses to ischemia, with a significant decrease in expression of genes related to the TCA cycle and electron transport chain in the kidneys and liver, in contrast to the brain. In an in vitro serum deprivation model, fumarate preserved mitochondrial potential in a cell type-specific manner, with optimal concentrations of 12.5 mM for astrocytes (p < 0.05), and 25 mM for renal (p < 0.01) or hepatic cells (p < 0.01). Under normal conditions, fumarate increased mitochondrial potential in astrocytes (p < 0.0001), with weak or no effect on renal and hepatic cells. Estimation of cell number indicates the effects of fumarate on the proliferation of kidney (p < 0.05) and liver (p < 0.0001) cells in normal conditions and cell death after serum deprivation. Conclusion: Bioinformatic analysis demonstrates that ischemic stress induces fundamentally different transcriptional programs in the brain, kidney, and liver, particularly affecting genes involved in mitochondrial bioenergetics. Complementing these findings, our in vitro data identify fumarate as a metabolically active but organ-dependent candidate for tissue protective strategies in substrate deprivation pathologies, like ischemia.
- Open Access
- 30 October 2023
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Problems of Geroscience
- No. 3,p. 127-133
Age-Related Changes in Kidney and Loss of Resistance to Damage: The Role of the Decrease in the Number of Kidney Progenitor Cells during Aging
Many organs undergo negative changes during aging that affect their functions and ability to regenerate. In particular, the kidneys become more susceptible to acute injury and are more likely to develop chronic kidney disease with age. One of the reasons for this may be a decrease in the number of kidney resident progenitor cells. This review addresses age-related changes that occur in the kidneys at the histological and molecular levels, including those related to the cell cycle, mitochondrial function, oxidative stress, and chronic inflammation. This review describes the available studies on resident kidney stem cells, their niches, morphology, possible markers, and the dynamics of their numbers during the aging process. The reasons for the age-related decline in renal regenerative potential are considered based on molecular and cellular mechanisms.
- 30 October 2023
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Problems of Geroscience
- No. 3,p. 127-133
Open AccessAge-Related Changes in Kidney and Loss of Resistance to Damage: The Role of the Decrease in the Number of Kidney Progenitor Cells during Aging
Many organs undergo negative changes during aging that affect their functions and ability to regenerate. In particular, the kidneys become more susceptible to acute injury and are more likely to develop chronic kidney disease with age. One of the reasons for this may be a decrease in the number of kidney resident progenitor cells. This review addresses age-related changes that occur in the kidneys at the histological and molecular levels, including those related to the cell cycle, mitochondrial function, oxidative stress, and chronic inflammation. This review describes the available studies on resident kidney stem cells, their niches, morphology, possible markers, and the dynamics of their numbers during the aging process. The reasons for the age-related decline in renal regenerative potential are considered based on molecular and cellular mechanisms.